FG-2101

• Description :

  FG-2101 is a selective and orally active non-hydroxamate LpxC inhibitor with an IC50 of ~1 nM. FG-2101 exhibits exquisite selectivity over other bacterial and human metalloenzymes. FG-2101 can be used for the study of Gram-negative bacteria infections including drug-resistant strains[1].

• UNSPSC :

  12352005

• Target :

  Bacterial

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Smiles :

  N#CC1CN(C1)C[C@H](C2=CC=C(C=C2)C#CC3=CC=C(C=C3)CN4CCOCC4)CC5=C(C(NC=N5)=O)OP(O)(O)=O

• Molecular Formula :

  C30H32N5O6P

• Molecular Weight :

  589.58

• References & Citations :

  [1]4185279-First disclosure of FG-2101: A novel non-hydroxamate inhibitor of LpxC for treating Gram-negative bacteria infections including drug-resistant strains.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2919723-66-1]